Belite Bio is a publicly traded company trading on NASDAQ, led by CEO Yu-Hsin Lin.
Upcoming earnings announcement for Belite Bio
Past 12 earnings reports for Belite Bio
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Q4 2025 | -$0.70Est: -$0.55 | -27.3% | - | — | — |
| Nov 10, 2025 | Q3 2025 | -$0.65Est: -$0.51 | -27.5% | - | — | — |
| Aug 11, 2025 | Q2 2025 | -$0.50Est: -$0.44 | -13.6% | - | — | — |
| May 13, 2025 | Q1 2025 | -$0.45Est: -$0.37 | -21.6% | - | — | — |
| Mar 17, 2025 | Q4 2024 | -$0.32Est: -$0.31 | -3.2% | - | — | — |
| Nov 12, 2024 | Q3 2024 | -$0.28Est: -$0.29 | +3.4% | - | — | — |
| Aug 9, 2024 | Q2 2024 | -$0.26Est: -$0.25 | -4.0% | - | — | — |
| May 13, 2024 | Q1 2024 | -$0.33Est: -$0.28 | -17.9% | - | — | — |
| Mar 11, 2024 | Q4 2023 | -$0.25Est: -$0.30 | +16.7% | - | — | — |
| Nov 13, 2023 | Q3 2023 | -$0.40 | — | - | — | — |
| Aug 8, 2023 | Q2 2023 | -$0.26 | — | - | — | — |
| May 10, 2023 | FY 2022 | -$0.33 | — | - | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.